ALB and hydrops fetalis: Furthermore, patients in albumin Q4 showed a significantly lower rate of the secondary endpoint of HF‐related rehospitalization at 30 months, compared to Q1‐3 (Q4: 7.6 vs. Q3: 14.3 and Q2: 16.0 and Q1: 14.5%; log rank p = .001 for all comparisons with Q4; Q3 vs. Q4: HR = 1.943; 95% CI 1.318–2.863; Q1 vs. Q4: HR = 1.999; 95% CI 1.346–2.970) (Figure 2, upper right panel).